Received Mar 19, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | U8372AA | IM / LL |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 3 | 2155634 | PO / MO |
Clinic notified on 3/19/2026: Per patient's mother, patient develops "hives from head to toe" following vaccines given on 3/16/2026. Hives were first noticed around 7:30PM but mother states they may have been present sooner and she didn't see them until she was changing baby's diaper and clothes for bedtime. Patient mom also notes patient was "very fussy and irritable."
general viral respiratory symptoms (nasal congestion/discharge, occasional cough)
newborn exposure to maternal syphillis, maternal substance abuse affecting newborn, exposure to alcohol in utero, small for gestational age, fetal growth restriction
famotidine PO
No known allergies
N/A
Vaxelis, Vaxneuvance and Rotateq given on 12/15/2025 (age 3 months). Reported "very high fever" (up to 104) and visible hives